NYSE:YOU
NYSE:YOUSoftware

Why Clear Secure (YOU) Is Up 11.3% After Landing a Pivotal Medicare.gov Identity Platform Deal

Earlier this month, CLEAR announced a contract with the Centers for Medicare & Medicaid Services to integrate its CLEAR1 identity platform into Medicare.gov from early 2026, while also rolling out CLEAR ID, a free mobile digital ID for TSA checkpoints, and expanding healthcare partnerships with Welldoc and Sharecare. Together, these moves extend CLEAR’s identity technology well beyond airports, embedding it into federal healthcare infrastructure and consumer health apps, which could deepen...
NYSE:IEX
NYSE:IEXMachinery

IDEX (IEX): A Fresh Look at Valuation After Recent Share Price Rebound

IDEX (IEX) has quietly climbed about 11% over the past 3 months, even as its year to date and 1 year returns remain negative. That mix of recovery and lag is drawing fresh attention. See our latest analysis for IDEX. Zooming out, that 30 day 7.7% share price return sits alongside a weak year to date share price performance and a negative one year total shareholder return. This suggests recent momentum is rebuilding as investors reassess IDEX’s growth and risk profile. If IDEX’s rebound has...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

The Bull Case For Victoria's Secret (VSCO) Could Change Following Upbeat Sales Outlook And Analyst Upgrade

In early December 2025, Victoria’s Secret & Co. reported third-quarter 2025 sales of US$1,472 million with a reduced net loss of US$37 million, raised its full-year 2025 net sales outlook to US$6.45–6.48 billion, and projected fourth-quarter net sales of US$2.17–2.20 billion, above last year’s US$2.106 billion. Wells Fargo’s upgrade of Victoria’s Secret, citing improving product and marketing execution and a rebound at PINK, suggests that recent operational changes are starting to influence...
NYSE:ADC
NYSE:ADCRetail REITs

What Agree Realty (ADC)'s Higher Monthly Dividend Says About Its Income Strategy and Risk‑Reward Balance

In December 2025, Agree Realty Corporation’s board approved and declared a higher monthly cash dividend of $0.262 per common share, equivalent to an annualized $3.144 and reflecting a 3.6% increase over the fourth-quarter 2024 rate, along with a monthly dividend of $0.08854 per Series A preferred depositary share. This dividend increase signals management’s confidence in the REIT’s cash flow profile and underscores its continued emphasis on delivering consistent income to both common and...
NasdaqGS:BWIN
NasdaqGS:BWINInsurance

Insider Sale and New Debt Capacity Could Be A Game Changer For Baldwin Insurance Group (BWIN)

Earlier in December 2025, Baldwin Insurance Group President James Morgan Roche sold 239,200 Class A shares for about US$5.74 million, while the company reported third-quarter earnings that exceeded analyst expectations and secured lender commitments for a US$600 million incremental term loan, lifting its facility to US$1.60 billion. This combination of insider selling, stronger-than-forecast financial results, and expanded borrowing capacity has sharpened investor focus on Baldwin’s growth...
NYSE:ZWS
NYSE:ZWSBuilding

Zurn Elkay Water Solutions (ZWS): Valuation Check After Upbeat Q3 Earnings and Fresh Analyst Buy Ratings

Analysts are warming up to Zurn Elkay Water Solutions (ZWS) after a wave of upbeat coverage following its better than expected third quarter earnings and raised full year guidance, and investors are paying attention. See our latest analysis for Zurn Elkay Water Solutions. That mix of upbeat earnings, raised guidance, and fresh Buy ratings appears to be feeding into a constructive trend, with a strong year to date share price return of 27.8 percent and a hefty three year total shareholder...
NasdaqGS:TBBK
NasdaqGS:TBBKBanks

Assessing Bancorp (TBBK) Stock’s Valuation After Its Strong Recent Share Price Performance

Recent performance and why Bancorp is on investors radar Bancorp (TBBK) has quietly outperformed this year, with the stock up about 31% year to date and roughly 22% over the past year, even after a recent 1% pullback. See our latest analysis for Bancorp. With the share price now around $67.58, Bancorp’s roughly 10% 1 month share price return contrasts with a softer 3 month patch, while a powerful multi year total shareholder return suggests momentum is pausing rather than breaking. If...
NasdaqGS:LIN
NasdaqGS:LINChemicals

Does Linde's (LIN) Insider Buying Reinforce Its Long‑Term Growth Story Or Raise New Questions?

In recent days, Linde has attracted renewed attention as multiple banks reiterated positive views on its long-term growth model, underpinned by a project backlog of over US$7.10 billion and continued shareholder returns via dividends and buybacks, following a period of softer industrial demand. An interesting development is the uptick in insider share purchases, including by CEO Sanjiv Lamba, which many investors interpret as a concrete signal of management’s confidence in Linde’s future...
NasdaqCM:AMPL
NasdaqCM:AMPLSoftware

Amplitude (AMPL) Valuation Check After New AI Platform Launch and Strategic Acquisitions

Amplitude (AMPL) is back on investors radar after launching a new AI platform and closing a string of strategic acquisitions, moves that are already showing up in longer contracts and renewed confidence from enterprise customers. See our latest analysis for Amplitude. Even with the AI launch and acquisitions grabbing attention, Amplitude's 1 year total shareholder return of negative 5.7 percent and modest year to date share price return of 3 percent suggest sentiment is only just starting to...
NasdaqGS:CZR
NasdaqGS:CZRHospitality

Caesars Entertainment (CZR) Valuation Check After New Rampart Casino Sportsbook Partnership in Las Vegas

Caesars Entertainment (CZR) is back in the Las Vegas spotlight after announcing a planned Caesars Sportsbook at Rampart Casino in Summerlin, pending approval. This move represents a strategic push deeper into local sports betting demand. See our latest analysis for Caesars Entertainment. Despite strategic moves like the Rampart sportsbook and the new Caesars Rewards Shop feature, Caesars Entertainment’s recent trading tells a mixed story, with a strong 1 month share price return of 20.83...
NYSE:REX
NYSE:REXOil and Gas

REX American Resources (REX): Reassessing Valuation After Stable Q3 Results and Softer Year-to-Date Profits

REX American Resources (REX) just posted its third quarter numbers, showing sales essentially flat year over year while earnings per share inched higher, even as year to date net income drifted lower. See our latest analysis for REX American Resources. That steadiness in the latest earnings comes after a strong run, with the share price up about 55% year to date and a 1 year total shareholder return of nearly 61%. This suggests positive momentum despite recent profit pressure. If REX's move...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

US High Growth Tech Stocks To Watch December 2025

As the United States market navigates a period of volatility, with major indexes closing lower amid concerns over an AI bubble and looming economic reports, investors are keenly observing the tech sector's dynamics. In such a climate, identifying high-growth tech stocks involves looking for companies with strong fundamentals and resilience to market pressures.
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

3 Stocks Estimated To Be Trading At Discounts Of 23.8% To 35.3%

As the United States stock market grapples with concerns over an AI bubble and fluctuating major indexes, investors are keenly observing economic indicators like the upcoming jobs report to gauge future market directions. In this environment of uncertainty, identifying stocks that are potentially undervalued can offer opportunities for those looking to capitalize on price discrepancies; such stocks may be trading at significant discounts relative to their intrinsic value, providing a...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Three Insider-Favored Growth Companies To Watch

As the U.S. stock market grapples with pressures on AI stocks and anticipates key economic data releases, investors are keenly observing how these factors influence broader market trends. In such a volatile environment, growth companies with high insider ownership often stand out as they suggest confidence from those closest to the business, making them intriguing prospects for investors seeking stability amid uncertainty.
NasdaqGM:ARTV
NasdaqGM:ARTVBiotechs

Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders

As the year draws to a close, U.S. markets are experiencing volatility, with major indexes closing lower amid concerns about an AI bubble and looming economic reports. In such a climate, investors often look beyond the large-cap stocks dominating headlines to explore opportunities in lesser-known areas like penny stocks. While the term "penny stocks" may seem outdated, it continues to signify smaller or emerging companies that could offer significant value when backed by strong financials and...
NasdaqGS:JJSF
NasdaqGS:JJSFFood

Top Dividend Stocks To Consider In December 2025

As the U.S. stock market navigates a challenging landscape with AI stocks under pressure and economic data closely watched, investors are increasingly seeking stability amid volatility. In such an environment, dividend stocks can offer a reliable income stream, making them an attractive option for those looking to balance potential risks with steady returns.
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Roper Technologies (ROP): Has the Recent Share Price Slide Opened a Valuation Opportunity?

Roper Technologies (ROP) has been drifting lower this year, with shares down about 14% year to date even as revenue and net income keep growing at a steady high single digit pace. See our latest analysis for Roper Technologies. That slide has left Roper with a roughly 13.6% year to date share price decline and a weaker 1 year total shareholder return. This suggests investors are reassessing how much they will pay for its steady but unspectacular growth profile. If Roper’s softer momentum has...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is Incyte’s 2025 Surge Justified by Cash Flow Outlook and Oncology Pipeline Progress?

Wondering if Incyte is still a smart buy after its big run, or if most of the upside is already priced in? This breakdown will help you decide whether the current share price offers real value or just story driven momentum. Incyte's stock is up 39.8% over the past year and 39.6% year to date, even after a recent 6.8% slide over the last month and a modest 2.0% bump in the last week around the $97.03 level. This suggests investors may be reassessing both its growth potential and risk...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health Investments (CLOV): Is the Market Undervaluing Its Tentative Share Price Recovery?

Clover Health Investments (CLOV) has quietly shifted gears this year, with the stock up around 7% over the past month even as its past 3 months performance remains negative. See our latest analysis for Clover Health Investments. That recent 6.9% 1 month share price return sits against a weak year to date share price performance and a still negative 1 year total shareholder return, suggesting sentiment is tentatively improving but far from fully convinced. If Clover’s move has you rethinking...